Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
trding's Profile
Displaying 1301-1350 of 2992 result(s).
CYDY CytoDyn Inc
09/26/2019 12:27:05 PM
Oh, maybe you were talking about th
CYDY CytoDyn Inc
09/26/2019 12:15:49 PM
Sorry BD, language was too figurati
CYDY CytoDyn Inc
09/26/2019 11:15:42 AM
Best line in the movie. My wife fou (1)
CYDY CytoDyn Inc
09/26/2019 6:26:04 AM
It is happened before, but I don’
CYDY CytoDyn Inc
09/26/2019 6:20:23 AM
Yes cabotegravir and rilpivirine An (1)
CYDY CytoDyn Inc
09/26/2019 12:05:52 AM
Also, do we know the exact meeting
CYDY CytoDyn Inc
09/25/2019 11:42:23 PM
The article yesterday had some inte (3)
CYDY CytoDyn Inc
09/25/2019 2:48:57 PM
Probably somebody in retail flippin
CYDY CytoDyn Inc
09/25/2019 7:00:53 AM
You want to see something crazy. I (1)
CYDY CytoDyn Inc
09/24/2019 2:54:40 PM
It aint over yet Fortuno. Lets wait (4)
CYDY CytoDyn Inc
09/24/2019 2:46:49 PM
Wow, I watch the show, had no idea.
CYDY CytoDyn Inc
09/24/2019 2:42:45 PM
Good article. Having been the CEO o (3)
CYDY CytoDyn Inc
09/24/2019 9:57:46 AM
150k buy order at 34c. Someone buyi (1)
CYDY CytoDyn Inc
09/24/2019 9:44:03 AM
32c support 36c resistance, two key (1)
CYDY CytoDyn Inc
09/24/2019 7:17:15 AM
Yes, this is why my first post to h
CYDY CytoDyn Inc
09/23/2019 11:08:54 PM
Yeah. I would also. I’ll add on t (3)
CYDY CytoDyn Inc
09/23/2019 10:33:10 PM
Question for you then: Why does NP (2)
CYDY CytoDyn Inc
09/23/2019 6:07:51 PM
I’m not actually saying they shou
CYDY CytoDyn Inc
09/23/2019 5:24:58 PM
So market is doubting the financing (3)
CYDY CytoDyn Inc
09/23/2019 5:09:25 PM
Yes, one reason trading around a co
CYDY CytoDyn Inc
09/23/2019 12:12:33 PM
I would do #1 buy at 32c. The price
CYDY CytoDyn Inc
09/23/2019 10:21:19 AM
We will see. I think if they had an
CYDY CytoDyn Inc
09/23/2019 9:53:42 AM
Yes, definitely. Looks like 35c is
CYDY CytoDyn Inc
09/23/2019 9:51:20 AM
Yeah, indeed. I should have waited
CYDY CytoDyn Inc
09/23/2019 9:44:18 AM
Just looked, hit 32c, wow. People w
CYDY CytoDyn Inc
09/23/2019 7:18:35 AM
Any idea which center the patient i
CYDY CytoDyn Inc
09/22/2019 5:43:11 PM
I don’t know but they aren’t ta (1)
CYDY CytoDyn Inc
09/22/2019 5:26:56 PM
Question for you then: Why does NP (1)
CYDY CytoDyn Inc
09/22/2019 5:13:19 PM
Okay a threat of a lawsuit. Anyway,
CYDY CytoDyn Inc
09/22/2019 4:32:04 PM
BTW, Here is the pic in RPs final v
CYDY CytoDyn Inc
09/22/2019 3:48:06 PM
My guess would be the ceo and cfo a
TONX TON Strategy Co.
09/22/2019 11:45:36 AM
https://www.cnbc.com/2019/09/22/da (3)
CYDY CytoDyn Inc
09/22/2019 11:40:38 AM
Lawsuit against certain iHub poster (3)
CYDY CytoDyn Inc
09/22/2019 7:28:26 AM
I agree, killing off the mono trial (2)
CYDY CytoDyn Inc
09/22/2019 7:23:21 AM
Thanks misiu. So CEO can’t legall (2)
CYDY CytoDyn Inc
09/21/2019 8:42:00 PM
They can't get enough participation (3)
CYDY CytoDyn Inc
09/21/2019 2:53:16 PM
I would settle for either Nader and (3)
CYDY CytoDyn Inc
09/21/2019 11:54:23 AM
Yes, looks like a push to secure fi (2)
CYDY CytoDyn Inc
09/20/2019 6:50:52 PM
Paulson people can’t simply delet
CYDY CytoDyn Inc
09/20/2019 3:12:46 PM
New article, not much new I saw on (2)
CYDY CytoDyn Inc
09/20/2019 11:33:39 AM
just need to shore up 525 or 700 an
CYDY CytoDyn Inc
09/20/2019 8:43:29 AM
Yes also remember the half-life of (1)
CYDY CytoDyn Inc
09/20/2019 8:36:24 AM
Understood, we will see. I’m expe (1)
CYDY CytoDyn Inc
09/20/2019 8:19:16 AM
Yes, maraviroc was able to enroll 1
CYDY CytoDyn Inc
09/20/2019 7:16:20 AM
Yes, IZ was the special case, they (2)
CYDY CytoDyn Inc
09/20/2019 7:09:39 AM
Agree BL, the science is strong, co (3)
CYDY CytoDyn Inc
09/20/2019 6:38:27 AM
The FDA has made some concessions. (3)
CYDY CytoDyn Inc
09/19/2019 6:07:28 PM
Oh, okay, I got a pm about it, didn (1)
CYDY CytoDyn Inc
09/19/2019 3:18:03 PM
Definitely some blunders along the (1)
CYDY CytoDyn Inc
09/19/2019 2:49:10 PM
This is a post discussing to the se
Go to page:
  • << First
  • < Previous
  • 26
  • 27
  • Next >

Recent Articles

  • Leadership Transition at Constellation Brands Set for 2026
  • Greif, Inc. Achieves Major Milestone with Timberlands Sale
  • ClarityPay Enhances Leadership with MJ Panda as COO for Growth
  • Greif, Inc. Strengthens Position with Timberlands Sale
  • Transforming Road Assessments: PaveX Innovates with AI Solutions
  • DataDasher Partners with Bento Engine to Empower Advisors
  • Advancements in Radiopharmaceuticals: A Game Changer for Oncology
  • SEI Investments Partners with Graphene for Wealth Growth
  • GraniteShares Unveils Weekly Yields for Its ETFs: Key Insights
  • Analyzing Netflix Stock Trends After Recent Musk Comments
  • Rubbermaid Commercial Products Celebrates Cleaning Heroes in 2025
  • CloudCasa Enhances Backup Solutions for Kubernetes and VMs
  • Innovative Visions: Elon Musk and Jensen Huang's AI Future
  • PaveX Revolutionizes Road Condition Assessment with AI Solutions
  • Collaboration between XenoSTART and Minerva Imaging in Drug Development
  • Maximizing Your Earnings with Apple Stock Dividends
  • Kalmar Strengthens Operations with New Noatum Ports Partnership
  • EPAM and BOSS Launch Groundbreaking Motorsport Experience
  • Navigating the Rapid Growth in 3D Semiconductor Packaging
  • Norfolk Southern Set to Release Its Q3 2025 Earnings Soon
  • Exploring Ambition and Authenticity in Soul Toll by Anusia Gillespie
  • Unlocking Brand Value: New Insights from TransUnion's Research
  • OpenAP Enhances Video Advertising Landscape for Increased Reach
  • Cocrystal Pharma to Showcase Innovations at a Key Investor Event
  • INOVIO's New Equity Grant: Empowering Innovative DNA Medicines
  • Empowering Change in Beauty with Maesa's Latest Incubator Class
  • Nuvini Group Implements Reverse Stock Split for Growth Strategy
  • LifeVantage Celebrates Acquisition of LoveBiome for Growth
  • Cetera Welcomes Paul Polese as New Community Leader
  • PharmaTher Focuses on Expanding Ketamine Portfolio and Strategy
  • DAR's Generous $2 Million Gift to Preserve Cherry Blossoms
  • Taysha Gene Therapies Receives Breakthrough Therapy Designation
  • Dianthus Therapeutics Set to Present Key Claseprubart Data
  • Newton Golf Company Celebrates Success at World Long Drive Event
  • CoreCivic to Release Third Quarter Earnings in November 2025
  • Partnership Insights: NEO Battery and North American Drone Maker
  • Apollo Global Management to Reveal Q3 Financial Outcomes Soon
  • Enphase Energy Partners with Essent for Innovative Solar Solutions
  • BioCardia Achieves Compliance with Nasdaq, Empowering Innovations
  • Alignment Healthcare Plans to Share Exciting Q3 Financials Soon
  • Westwood ETFs Provide Impressive Monthly Income for Investors
  • CervoMed Engages at 4th Annual ROTH Healthcare Conference
  • LiveOne Partners with BKFC for Ice Wars 3 Event Streaming
  • Sonoro Gold's $3 Million Private Placement Fuels Future Growth
  • Innovative ZUSDURI™ Treatment for Bladder Cancer Reviewed
  • Leadership Transition at Constellation Brands: A New Era Begins
  • Shattuck Labs Engages with Key Opinion Leaders at Conference
  • Quantum BioPharma Progresses on Multiple Sclerosis Treatment
  • Premier Health Navigates Public Contract Challenges in Quebec
  • Catherine Clay Appointed CEO to Lead S&P Dow Jones Indices
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site